Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator.
Oliver L, Alvarez R, Diaz R, Valdés A, Colligan SH, Nemeth MJ, Twum DYF, Fernández A, Fernández-Medina O, Carlson LM, Yu H, Eng KH, Hensen ML, Rábade-Chediak ML, Fernández LE, Lee KP, Perez L, Muhitch JB, Mesa C, Abrams SI.
Oliver L, et al. Among authors: hensen ml.
J Immunother Cancer. 2022 Sep;10(9):e004710. doi: 10.1136/jitc-2022-004710.
J Immunother Cancer. 2022.
PMID: 36150744
Free PMC article.
Clinical Trial.